Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Chinese Patent Office
Cipla
AstraZeneca
Accenture
Teva
Medtronic
McKinsey

Generated: June 19, 2018

DrugPatentWatch Database Preview

HEPARIN SODIUM PRESERVATIVE FREE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Heparin Sodium Preservative Free, and what generic alternatives are available?

Heparin Sodium Preservative Free is a drug marketed by Fresenius Kabi Usa, Hospira, Pfizer, Pharma Serve Ny, Sagent Pharms, Shenzhen Techdow, and Watson Labs Inc. and is included in eight NDAs.

The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for HEPARIN SODIUM PRESERVATIVE FREE
Drug patent expirations by year for HEPARIN SODIUM PRESERVATIVE FREE
Pharmacology for HEPARIN SODIUM PRESERVATIVE FREE

US Patents and Regulatory Information for HEPARIN SODIUM PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 017029-010 Apr 28, 1986 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharma Serve Ny HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 086129-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 005264-014 Apr 7, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sagent Pharms HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 090810-001 Jun 30, 2010 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Mallinckrodt
Chubb
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.